AVEO Oncology slips 10% despite deal to evaluate Fotivda in combination for kidney cancer
06 January 2022 - 03:21AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Feb 2024 to Mar 2024
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Mar 2023 to Mar 2024